These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8478265)

  • 1. Implication of cohesive binding of a macrolide antibiotic, rokitamycin, to ribosomes from Staphylococcus aureus.
    Endou K; Matsuoka M; Taniguchi H; Nakajima Y
    J Antibiot (Tokyo); 1993 Mar; 46(3):478-85. PubMed ID: 8478265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adhesive binding of rokitamycin to Staphylococcus aureus ribosomes.
    Endou K; Matsuoka M; Nakajima Y
    FEMS Microbiol Lett; 1990 Oct; 60(1-2):93-6. PubMed ID: 2283045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labile 50S ribosome from partial macrolide-resistant Staphylococcus aureus.
    Endou K; Endoh S; Matsuoka M; Nakajima Y
    Biol Pharm Bull; 1993 Mar; 16(3):328-30. PubMed ID: 8364485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope].
    Yano H; Kobayashi T; Okitsu N; Aoki A; Toriya M; Nakada Y; Sagai H; Iyobe S; Inoue M
    Jpn J Antibiot; 2007 Feb; 60(1):31-46. PubMed ID: 17436861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postantibiotic effects (PAE's) of macrolide antibiotics evaluated using Bioscreen C method].
    Okubo T; Suzuki T; Fujita K; Iyobe S; Inoue M
    Jpn J Antibiot; 1995 Apr; 48(4):548-52. PubMed ID: 7783317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical studies of rokitamycin dry syrup on skin and soft tissue infections in the pediatric fields].
    Motohiro T; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Fujimoto T; Sakata Y; Nishiyama T; Yamashita F
    Jpn J Antibiot; 1988 Oct; 41(10):1503-16. PubMed ID: 3204657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro antimicrobial activity of rokitamycin, a macrolide antibacterial agent, against clinically isolated strains of Campylobacter and other enteritis-causing bacteria].
    Horiuchi S; Inagaki Y; Chida T; Nakaya R
    Kansenshogaku Zasshi; 1991 Oct; 65(10):1325-30. PubMed ID: 1791330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro assessment of rokitamycin against problem gram-positive cocci.
    Hamilton-Miller JM; Maple PA
    J Chemother; 1992 Feb; 4(1):6-8. PubMed ID: 1403073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antimicrobial activities of macrolides against recent clinical isolates, and analysis of resistant mechanisms].
    Okubo T; Iyobe S; Fujiki Y; Sagai H
    Jpn J Antibiot; 2003 Jun; 56(3):163-70. PubMed ID: 12942787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and localization of a determinant conferring partial macrolide resistance in Staphylococcus aureus carrying plasmid.
    Matsuoka M; Endou K; Yagi K; Nakajima Y
    Biol Pharm Bull; 1993 Jul; 16(7):711-3. PubMed ID: 8401408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of YM133, a new semisynthesized macrolide.
    Terasawa T; Watanabe M; Okubo T; Mitsuhashi S
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1370-5. PubMed ID: 1929295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibacterial activity of rokitamycin against fresh clinical isolates].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Dec; 45(12):1609-21. PubMed ID: 1289579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bacteriological, pharmacokinetic and clinical studies on a rokitamycin dry syrup in the pediatric field].
    Toyonaga Y; Sugita M; Joh K; Takahashi T; Watanabe Y; Hori M
    Jpn J Antibiot; 1988 Jun; 41(6):720-38. PubMed ID: 3265445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on susceptibility of isolated organisms from pediatric infections against various antimicrobial agents].
    Fujii R; Shinozaki T; Meguro H; Arimasu O; Yoshioka H; Fujita K; Sakata H; Maruyama S; Wagatsuma Y; Fukushima N
    Jpn J Antibiot; 1988 Jul; 41(7):841-53. PubMed ID: 3050184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity of rokitamycin compared with that of other macrolides.
    Yu KW; Briones F; Chin NX; Neu HC
    Diagn Microbiol Infect Dis; 1991; 14(4):331-5. PubMed ID: 1889182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative comparison of the cytocidal effect of seven macrolide antibiotics on human periodontal ligament fibroblasts.
    Maizumi N; Tamura Y; Kanai H; Tsutsui T
    J Periodontal Res; 2002 Aug; 37(4):250-4. PubMed ID: 12200967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phagocytosis and intracellular killing of rokitamycin-exposed staphylococci by human polymorphonuclear leukocytes.
    Braga PC; Sala MT; Mancini L; Da Sasso M
    Chemotherapy; 1998; 44(1):42-9. PubMed ID: 9444408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A quantitative determination of inducibility by 14 membered ring macrolide antibiotics in inducible resistant Staphylococcus aureus to macrolide-lincosamide-streptogramin B antibiotics].
    Kobayashi H; Endou K; Nakajima Y
    Yakugaku Zasshi; 1994 Dec; 114(12):1015-20. PubMed ID: 7869234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The post-antibiotic effects of rokitamycin (a 16-membered ring macrolide) on susceptible and erythromycin-resistant strains of Streptococcus pyogenes.
    Braga PC; Culici M; Dal Sasso M
    Int J Antimicrob Agents; 2004 Sep; 24(3):254-60. PubMed ID: 15325429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rokitamycin: bacterial resistance to a 16-membered ring macrolide differs from that to 14- and 15-membered ring macrolides.
    Braga PC
    J Chemother; 2002 Apr; 14(2):115-31. PubMed ID: 12017366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.